Drug delivery device tested in healthy volunteers
NCT ID NCT06475729
Summary
This study tested whether a new, larger autoinjector device delivers the drug mirikizumab into the body in the same way as the currently used, smaller device. It involved 498 healthy volunteers who received injections under the skin. The main goal was to compare how much drug gets into the blood and how long it stays when using the two different devices.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel ACT
Anaheim, California, 92801, United States
-
Clinical Pharmacology of Miami
Miami, Florida, 33014-3616, United States
-
Fortrea Clinical Research Unit
Daytona Beach, Florida, 32117, United States
-
Fortrea Clinical Research Unit
Dallas, Texas, 75247, United States
-
Fortrea Clinical Research Unit
Madison, Wisconsin, 53704, United States
-
QPS Missouri
Springfield, Missouri, 65802, United States
Conditions
Explore the condition pages connected to this study.